Why the study?
Primary PCI is the preferred strategy for STEMI, but its efficacy remains unclear in very older adult patients.
Does primary PCI improve survival compared to conservative treatment in older adult patients (>75 years) with acute STEMI?
Does primary PCI improve survival compared to conservative treatment in older adult patients (>75 years) with acute STEMI?
Primary PCI is associated with a significant survival benefit compared to conservative treatment in older adults (>75 years) presenting with STEMI, supporting its use as the default strategy in this population.
Invasive approach linked to lower 30-day mortality in elderly STEMI; leaves open whether it should guide practice without randomized confirmation.
BACKGROUND: Primary percutaneous coronary intervention (PCI) is the preferred treatment strategy for patients with ST-elevation myocardial infarction (STEMI); however, its efficacy remains unclear in very older adult patients with STEMI. METHODS: This retrospective single-center observational study included 530 patients aged >75 years admitted to Tel Aviv Sourasky Medical Center with a diagnosis of acute STEMI. Primary PCI was performed for patients with symptoms ≤12 hours in duration, while the other patients were conservatively treated. We evaluated 30-day mortality and complications occurring during hospitalization based on data from patient records. RESULTS: Among the study patients, only 28/530 (5%) were conservatively treated. In-hospital complications, including the use of inotropes or intra-aortic balloon counterpulsation and the need for mechanical ventilation, did not differ significantly between the groups. The only parameter that showed a trend toward significance was the incidence of heart failure during hospitalization (p=0.042). The risk for 30-day mortality was substantially higher in the conservative treatment group than in the invasive treatment group (27% vs. 10%; p = 0.02). CONCLUSION: Our data suggested that despite concerns regarding the safety of the primary PCI strategy in the older adult STEMI population, this treatment strategy was associated with a survival benefit.
No takes yet. Share an insight, caveat, or question.
Rozenfeld et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: